Iroko hires Novartis' Clarence Young as CMO
This article was originally published in Scrip
Executive Summary
Philadelphia-based Iroko Pharmaceuticals, a pharma company developing specialty therapeutic products, has appointed Dr Clarence Young chief medical officer, reporting to John Vavricka, the company's president and CEO. Dr Young joins Iroko from Novartis Pharmaceuticals where he was vice-president of targeted therapies and integrated hospital care.